Performance of 68Ga-PSMA PET/CT for Prostate Cancer Management at Initial Staging and Time of Biochemical Recurrence

Jason J. Bailey,Morand Piert

Performance of 68Ga-PSMA PET/CT for Prostate Cancer Management at Initial Staging and Time of Biochemical Recurrence

2017

Jason J. Bailey
Morand Piert

Purpose of the Review Recently introduced Gallium-68 labeled PSMA-ligands such as HBED-CC (68Ga-PSMA) have shown promise for unmet diagnostic needs in prostate cancer.

Keywords:

PET-CT
Prostate cancer
Radiology
Biochemical recurrence
Glutamate carboxypeptidase II
68Ga-PSMA-11
Oncology
Stage (cooking)
Medicine
Internal medicine
Disease
Nephrology
Positron emission tomography

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations